INTRODUCTION
Non-communicable respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis and lung cancer are the third leading cause of global mortality. 1 2 In Australia, mortality from chronic respiratory disease is currently 25.6 deaths per 100 000 males and 15.5 deaths per 100 000 females aged <70 years. 3 In addition, these diseases can have extrapulmonary manifestations and therefore worsen the burden placed on healthcare resources. 3 Without well-informed policy there is likely to be further demand on healthcare expenditure. 4 The ability to identify those at highest risk of non-communicable respiratory disease could inform health policy that prevents the onset or limit the progression of lung disease.
Spirometry is a well-established clinical tool for assessing, diagnosing and monitoring respiratory disease in children and adults. It is a non-invasive method which allows to identify individuals with low or abnormal lung function, and compare both individuals and populations to international reference values. 5 For example, a recent population study of spirometry data from 2066 Australian subjects aged 4-80 years reported a mean difference of <0.25 for forced expiratory Strengths and limitations of this study ► Population-based sampling of Australian children provides a contemporary reference for future studies investigating lung function. ► This is the largest cross-sectional study to investigate lung function concordance in Australian parent-child dyads, thereby providing new insight into cross-generational patterns. ► Results were not adjusted for sitting height, which should be taken into consideration when interpreting the results. ► Most of the participating parents were mothers, resulting in less precise descriptive and concordance estimates for fathers.
Open access volume in 1 s (FEV 1 ) and forced vital capacity (FVC) reflecting substantial agreement with international standards. 6 The current literature also demonstrates clear modifiable, environmental risk factors for chronic respiratory disease, such as smoking and occupational exposures. 7 In childhood, genetic factors and developmental influences also appear to be relevant. Early life evidence suggests that the complex causal pathways to several non-communicable diseases occur in childhood through a variety of biopsychosocial factors. 8 For example, Tai et al found that lung function in adult life is mainly determined in childhood, and that those with lower lung function in childhood were more likely to have asthma and COPD later in life. 9 In addition, low FEV 1 in early adulthood contributes significantly to the genesis of COPD in later years. 10 Published studies provide consistent evidence for familial aggregation of spirometric indices, suggesting that around 20%-60% of total phenotypic variance may be explained by familial factors, [11] [12] [13] [14] [15] [16] but few studies have quantified intergenerational concordance at the population level. This could lead to new ways of predicting the population risk of non-communicable respiratory disease or even the possibility of targeted screening to individuals when a relative is identified with a heritable condition. 17 The Child Health CheckPoint, nested within the Longitudinal Study of Australian Children (LSAC, also known as Growing Up in Australia), offered a comprehensive health assessment to participants. This included lung function testing of children aged 11-12 years and one of their parents using reliable, valid epidemiological measures, specifically FEV 1 , FVC and mid expiratory flow (MEF), on the same day and using the same equipment and protocols. Drawing on this population-based sample, the aims of this study were to (1) describe the epidemiology of lung function in Australian children aged 11-12 years and their parents and (2) investigate parent-child concordance in these same measures.
METHODS

Study design and participants
LSAC is Australia's only national longitudinal child study. Details of the LSAC study design and recruitment are provided elsewhere. [18] [19] [20] Briefly, commenced in 2004 as the B and K cohorts, data collection has taken place every 2 years. This included home visits and mailed questionnaires. The LSAC B cohort (reported in this paper) included 5107 families in the first wave, a 57.2% uptake of the 8921 families contacted. After 10 years of the study, 4484 of these families participated in wave 6 (2014) . During this wave 6 home visit, B cohort families were introduced to the upcoming Child Health CheckPoint and asked to consent to their contact details being shared with the CheckPoint team. Those who consented (3513 families, 78% of wave 6 cohort and 69% of original cohort) received an information pack via mail, and an information and recruitment phone call during 2015.
Child Health CheckPoint data collection spanned February 2015 to March 2016, and 1874 families participated (figure 1). In seven major Australian cities, the study child and one of their parents were invited to participate in a 3.5-hour clinic assessment which included 17 different assessment stations. In eight regional towns, there were 2.75-hour mini assessment centres, which included the same assessments as those made in major cities except for those requiring large equipment that could not be checked in as personal luggage on commercial flights. Families unable to attend a clinic appointment were offered a 1.5-hour home visit with a subset of measures that could be conducted in the home by a researcher using portable equipment. A more detailed description of the CheckPoint study design is provided elsewhere. 21 
22
Consent
The attending parent provided written informed consent for themselves and their child to participate in the study.
Patient and public involvement
Because LSAC is a population-based longitudinal study, no patient groups were involved in its design or conduct. To our knowledge, the public was not involved in the study design, recruitment or conduct of the LSAC study or its CheckPoint module. Parents received a summary health report for their child and themselves at or soon Figure 1 Participant diagram. n, number of families; c, number of children; p, number of attending adults; MAC, main assessment centre; mAC, mini assessment centre; HV, home visit assessment; LSAC, longitudinal study of Australian Children. *Unable to assess due to equipment failure, poor quality data or time contraints.
∧ Data from 20 non-biological child-parent pairs excluded from concordance analyses.
Open access after the assessment visit. Parents consented to take part knowing that they would not otherwise receive individual results about themselves or their child.
Procedures
Spirometry, height and weight were measured at an assessment centre or at a home visit. Participants were included in these analyses if they met American Thoracic Society (ATS)/European Respiratory Society (ERS) criteria for spirometry (see the Lung function measures section). Reasons for a lack of useable data included equipment failure, poor quality data or time constraints. Data from 20 non-biological child-parent pairs were excluded from concordance analyses.
Lung function measures
Participants completed spirometry testing with measures including FEV 1 ,FVC and MEF. Prior to testing, spirometers were calibrated using a 3 L syringe with adjustments made for current ambient conditions. Spirometry was performed using a Vyntus Pneumo spirometer running SentrySuite software (Care Fusion, Germany) with a bacterial filter and nose clip in place. These data were converted to z-scores using the Global Lung Initiative (GLI) 2012 reference equations. 23 Children also undertook postbronchodilator spirometry, which is not reported here.
Spirometry was performed in accordance with ATS/ ERS guidelines. 5 First, the researcher explained and demonstrated the correct performance of spirometry to study participants. This included an emphasis on correct posture with the head slightly elevated, a tight seal around the mouthpiece with no leak, a rapid and complete inhalation to total lung capacity, followed by a rapid maximal exhalation until residual volume was reached while maintaining an upright posture. Adhering to these instructions, participants then performed a minimum of three and a maximum of eight spirometry trials. Via its DataCube function, data were exported from the SentrySuite platform into a Microsoft Excel spreadsheet. The quality of all flow-volumes loops were assessed by LW and SR. Data were assessed to determine if the loops met ATS/ERS criteria (see the ATS/ERS acceptability criteria section), if two acceptable manoeuvres were obtained, each participant's best loop was identified. FEV 1, FVC and MEF scores were derived from the best loop.
ATS/ERS Acceptability Criteria
A. Start of test
Assessed by visual inspection of the flow-volume trace.
A rapid rise to and clearly defined peak expiratory flow.
B. Within manoeuvre
Assessed by visual inspection of the flow-volume trace. Manoeuvre was free from artefact, cough within the first second, glottic closure or obvious leak.
C. End of test
Assessed by visual inspection of the volume-time trace.
Clear end-expiratory plateau on volume-time trace with no sharp drop or cessation of flow. There was no specification for a minimal forced expiratory time. D. Repeatability
Two largest FEV 1 and FVC values were within 150 mL. A quality score between 1 and 5 was assigned to each loop. 1. Meets all of the ATS/ERS criteria (met acceptability criteria for A, B, C and D). 2. Meets all ATS/ERS criteria except for repeatability.
Two largest FVC values had a difference of >150 mL. 3. Meets all ATS/ERS criteria except for repeatability.
Two largest FEV 1 values had a difference >150 mL. 4. Does not meet ATS/ERS guidelines; data excluded from dataset. 5. Meets all ATS/ERS criteria except for repeatability.
Two largest FVC and FEV 1 values had a difference >150 mL.
Loops that were assigned a quality control score of 1, 2, 3 or 5 were included in the dataset.
Other sample characteristics Age and gender were obtained via the Medicare Australia database for children and were self-reported by parents. In Australia, socioeconomic indexes for areas provide standardised scores for socioeconomic status by geographic area (postcode of family domicile) compiled from 2011 Australian census data. We used the index of relative socioeconomic disadvantage (disadvantage index) which numerically summarises the social and economic status of Australian neighbourhoods (national mean of 1000 and an SD of 100, with a higher score indicating less disadvantage and a lower score indicating more disadvantage). 24 Height and weight were recorded prior to spirometry measurement. Standing height was measured to the nearest 0.1 cm without shoes and socks, in duplicate, using a portable rigid stadiometer (Invicta IP0955, Leicester, UK). A third measurement was taken if the difference of the first two measurements exceeded 0.5 cm; final height was the mean of all measurements made. Weight to the nearest 0.1 kg was measured wearing light clothing without shoes or socks using an InBody230 bioelectrical impedance analysis scale (Biospace Co., Seoul, South Korea) at assessment centres or with a 2-limb body composition scale (Tanita BC-351, USA) at home visits. Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. For children, an age-adjusted and sex-adjusted BMI z-score was calculated using the US Centers for Disease Control growth reference charts. 25 A preclinic checklist including questions about a diagnosis of asthma and shortness of breath causing restriction was completed by parents and brought to the assessment.
Statistical analysis
Statistical analyses were performed using Stata V.14.2. Continuous descriptive variables were summarised using weighted means and SD; categorical variables were summarised by number and weighted percentage for Open access children and adults separately, by sex and overall. The approximate normality or otherwise of the data's distributions were assessed through visual inspection.
Population summary statistics and proportions were estimated by applying survey weights and survey procedures that corrected for the sampling frame, participation and non-response, and took into account clustering in the sampling frame. SEs were calculated taking into account the complex design and weights. 26 More detail on the calculation of the survey weights is provided elsewhere. 27 Parent-child concordance was assessed by (1) Pearson's correlation coefficients with 95% CIs and (2) linear regression with the child variable as the dependent variable and the parent variable as the independent variable adjusted for the potential confounders. The Pearson's correlation and linear regression analyses were repeated using weighted multilevel survey analyses; as these yielded similar results, unweighted results are presented.
An abnormal FEV 1 /FVC z-score was defined as any result < −2.0. Study data were collected and managed using Research Electronic Data Capture electronic data capture tools. 28 Figure 1 depicts participation in the Child Health CheckPoint study. One thousand seven hundred and fifty-nine children and 1774 parents successfully completed spirometry testing in line with ATS/ERS criteria, 5 including 1668 biological parent-child dyads.
RESULTS
Sample characteristics
Sample characteristics are presented in table 1. Among the child cohort, boys and girls were roughly equally represented (51.2% boys), but most (87.5%) parents were mothers. For children, the sample population had a somewhat higher mean BMI than the historical reference population, in keeping with the known current epidemiology of BMI for Australian children. For parents, mean BMI fell within the 'overweight' category according to the US Centers for Disease Control and Prevention. 25 The mean disadvantage index was 1009 (62) which is marginally above the Australian national mean of 1000, but with a lower spread (SD 62 vs 100 nationally) such that very disadvantaged families were under-represented. 29 Two hundred and forty-one children (13.7%) and 179 parents (10%) reported a diagnosis of asthma. Only 11 children and 24 parents reported shortness of breath causing restriction. table 2 ). The proportion of children with lung function z-score below the normal range (< -2 z-score) was 1.7% for FEV 1 ; 0.6% for FVC; 12.9% for FEV 1 /FVC and 8.1% for MEF, respectively. This was similar in parents, where the proportion of lung function below the lower limit of normal was 2.7% for FEV 1 ; 1.3% for FVC; 13.7% for FEV 1 /FVC ratio and 7.9% for MEF, respectively.
Parent-child concordance
Two models of child-parent concordance are displayed in table 3. Pearson's correlations between children and parents for FEV 1 , FVC and MEF z-score all showed modest significant positive correlations. The strongest association was seen in FEV 1 /FVC z-score (correlation coefficient 0.25, 95% CI 0.20 to 0.29). Associations strengthened marginally on conversion to z-scores and thereby adjusting for age, sex and height. The linear regression model also showed similar relationships between child and parent lung function indices, when adjusted for covariates (child and parental age, sex, BMI and parental smoking at wave 6), irrespective of the parent being a mother or a father.
When using a FEV 1 /FVC ratio z-score of < −2.0 to define abnormality we found the following: parent and child both normal, 1282 (77.6%); parent abnormal but child normal, 163 (9.9%); parent normal but child abnormal, 159 (9.6%); both abnormal 49 (3.0%).
DISCUSSION
Principal findings
This study represents the largest report of spirometry in children aged 11-12 years across Australia. Lung function parameters were on average within normal limits for parents and children, with mean above the international predicted mean for FEV 1 and FVC while being below the predicted mean for FEV 1 /FVC. With regard to concordance, there were modest positive correlations between child and parent lung function indices of around 0.20-0.25 including FEV 1 , FVC and MEF. Importantly, the strongest concordance between children and parents was for the FEV 1 /FVC z-score, which represents the relationship between airway size and lung volume and is the most sensitive spirometric index for detecting airway obstruction.
Strengths and limitations
Within this large child cohort there was equal representation from boys (51.2%) and girls, but mothers were over-represented (87.5%). Nonetheless, the 221 fathers showed very similar patterns in the four parameters and their z-scores to mothers and to the children, although with some loss of precision in their estimates. Despite this, we recognise that we probably do not have a random selection of mothers and fathers, and suggest that our results should therefore be interpreted with the acknowledgement that the father sample could be biased. Importantly, a large proportion of mothers could also be viewed as a strength of our study given the influence of maternal factors and in utero environment on the future development of non-communicable disease. 30 We acknowledge that this was a cross-sectional study but highlight that our analyses have been adjusted for current parental smoking. Although smoking rates in Australia have declined significantly and are currently at their lowest levels in history, 30 it is well established that exposure to smoking can have a life-long impact on peak lung function. 31 Interpretation in light of current literature Compared with previous population studies of lung function, we showed somewhat larger mean absolute volumes for FEV 1 and FVC in children and adults of similar age and height. 32 Hall et al defined the minimum physiologically relevant difference to be 0.5 z-scores, equating to a difference of ∼6% predicted in their study of contemporary Australasian individuals. Mean (SD) z-scores for their data were 0.23 (1.00) for FEV 1 , 0.23 (1.00) for FVC, −0.03 (0.87) for FEV 1 /FVC and 0.07 (0.95) for FEF , all of which were considered well within the range considered to be physiologically irrelevant. 6 When adjusted for age, sex and height using the GLI prediction models, 23 mean FEV 1 , FVC and MEF z-scores were all within normal limits for children and their parents but above the GLI predicted mean, with patterns similar to but more marked than identified by Hall et al. This suggests that on average children, and their parents, in Australia have better lung volumes than the GLI reference population. This could be associated with the lower prevalence of smoking in Australia or that those with significant disadvantage, who might have lower lung function, were relatively under-represented in this study.
The FEV 1 /FVC ratio was below normal in ~13% of either children or their parents. This ratio reflects airway size relative to lung volume and might be explained by the concept of dysanaptic growth where the airways and lung parenchyma grow disproportionately. This is thought to be influenced by gender-specific pubertal status. A low ratio can indicate airway obstruction. Differences in technique and equipment may also have contributed. For example, suboptimal effort during the initial part of a forced expiratory manoeuvre, where flows remain partly effort-dependent, could underestimate FEV 1 but FVC would be preserved if the expiration proceeded to residual volume (akin to a slow vital capacity manoeuvre). Even though all Open access Open access flow-volume loops were inspected, it is possible that subtle suboptimal efforts could have gone undetected, thereby underestimating FEV 1 . However, the similarities with the findings of those reported by Hall et al suggest that our findings are replicable. Additionally, FVC increases with sitting height, and a lower FEV 1 /FVC ratio might occur Open access if our population was of greater sitting height than the reference population but we were not able to adjust for this as sitting height was not measured. 33 Matched FEV 1 / FVC ratio below the normal range occurred in only 3% of child-parent dyads.
All measurements were reported from prebronchodilator flow-volume loops as was reported in the lung function reference populations. We successfully measured response to bronchodilator (following 400 μg salbutamol) in 179 children with FEV 1 /FVC ratio < −2 z-scores (data not shown). Fifty-three (30%) had evidence of a significant response to bronchodilator (defined as ≥12% and ≥200 mL improvement in absolute FEV 1 ), suggesting that many children with this ratio below the normal range have reversible airways obstruction. This is usually considered a characteristic feature of asthma.
Our intergenerational concordance findings for lung function extend the small published literature on the heritability and familial aggregation of lung function. 14 34 35 In the oldest published study dating back to 1984, Lebowitz et al did not find any relationship between parents' and children's lung function after accounting for body habitus. 34 whose narrow-sense heritability (which takes into account contributions from both parents) for FEV 1 and FVC were 38.9% and 40.6%. In contrast to the Busselton study where assessments were made at an offspring age of 45 years, we identified this concordance when children were between 11 and 12 years of age, prior to the likely influence of cigarette smoking and genetic susceptibility to lung injury on heritability. Xu et al identified significant correlations in parent child lung function in both families of children with asthma and healthy, non-asthmatic children. In healthy children, this correlation was similar for maternal (0.22) and paternal first child (0.24) FEV 1 , both again being remarkably similar to those identified in the current study. These data indicate that heritability of lung function requires further exploration when considering long-term outcomes of early lung function. 35 Meaning and interpretation for clinicians and policymakers Taken together, these results show lung volumes above predicted population means for Australian children aged 11-12 years and positive intergenerational concordance Open access between their lung function and those of their parents. Though modest, the associations highlight the potential for better identification of 'at risk' patients while also indicating that there are likely to be many other factors at play. If parents manifest low lung function then it is possible that targeting their offspring for screening and potential intervention might serve to prevent low lung function or lung function decline in the child.
Conclusions and future directions
Lung function indicating lower airway size relative to lung volume in this population may be due to multiple factors but warrants further assessment over time for evidence of airway obstruction. Our findings indicate the need to explore factors relating to intergenerational concordance in lung function further in order to develop health policy that aims to prevent the onset or limit the progression of lung disease. . The MCRI administered the research grants for the study and provided infrastructural support (IT and biospecimen management) to its staff and the study, but played no role in the conduct or analysis of the trial. DSS played a role in study design; however, no other funding bodies had a role in the study design and conduct; data collection, management, analysis and interpretation; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication. Research at the MCRI is supported by the Victorian Government's Operational Infrastructure Support Program.
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